383 related articles for article (PubMed ID: 19944096)
1. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
2. Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Andersson DR; Nissbrandt H; Bergquist F
Eur J Neurosci; 2006 Jul; 24(2):617-24. PubMed ID: 16903863
[TBL] [Abstract][Full Text] [Related]
3. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
Miller AD; Forster GL; Yeomans JS; Blaha CD
Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
[TBL] [Abstract][Full Text] [Related]
4. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
5. Effects of scopolamine on dopamine neurons in the substantia nigra: role of the pedunculopontine tegmental nucleus.
Di Giovanni G; Shi WX
Synapse; 2009 Aug; 63(8):673-80. PubMed ID: 19360852
[TBL] [Abstract][Full Text] [Related]
6. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat.
Miller AD; Blaha CD
Eur J Neurosci; 2005 Apr; 21(7):1837-46. PubMed ID: 15869479
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
8. Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning.
Akita H; Ogata M; Jitsuki S; Ogura T; Oh-Nishi A; Hoka S; Saji M
Brain Res; 2006 Jun; 1095(1):178-89. PubMed ID: 16729982
[TBL] [Abstract][Full Text] [Related]
9. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
10. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
[TBL] [Abstract][Full Text] [Related]
11. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.
Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y
J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664
[TBL] [Abstract][Full Text] [Related]
12. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
[TBL] [Abstract][Full Text] [Related]
14. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
[TBL] [Abstract][Full Text] [Related]
16. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
17. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
18. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease.
Cass WA; Peters LE; Smith MP
Brain Res; 2005 Feb; 1034(1-2):153-61. PubMed ID: 15713267
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
[TBL] [Abstract][Full Text] [Related]
20. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
Da Cunha C; Wietzikoski EC; Ferro MM; Martinez GR; Vital MA; Hipólide D; Tufik S; Canteras NS
Behav Brain Res; 2008 Jun; 189(2):364-72. PubMed ID: 18328580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
